pneumonia
remain
major
contributor
mortal
morbid
worldwid
age
group
lead
caus
death
infant
children
global
exceed
combin
mortal
malaria
tuberculosi
hiv
infect
lung
constantli
expos
microorgan
combin
effect
pathogen
host
environment
factor
determin
whether
clinic
condit
known
pneumonia
occur
pneumonia
gener
preval
lowand
middleincom
countri
incid
highest
extrem
age
elderli
infant
overwhelm
major
pneumonia
death
infant
young
children
occur
lowincom
set
number
classif
pneumonia
use
implic
etiolog
manag
prognosi
classif
base
origin
infect
sever
term
communityacquir
pneumonia
cap
refer
appear
infect
nonhospit
popul
risk
factor
multidrugresist
pathogen
wherea
term
hospit
acquir
pneumonia
nosocomi
pneumonia
use
evid
infect
present
incub
time
hospit
admiss
latter
type
pneumonia
frequent
found
patient
receiv
mechan
ventil
henc
term
ventilatorassoci
pneumonia
anoth
classif
common
use
children
communityacquir
pneumonia
resourcelimit
set
base
clinic
sever
use
guid
manag
decis
antibiot
treatment
hospit
oxygen
therapi
pneumonia
lead
caus
death
infant
young
children
month
year
age
worldwid
common
caus
death
newborn
month
age
pneumonia
account
around
onefifth
underf
mortal
global
walker
et
al
malaria
hiv
tuberculosi
combin
million
episod
pneumonia
million
sever
pneumonia
episod
million
death
due
pneumonia
infant
children
younger
year
year
risk
overwhelm
burden
pneumonia
lowincom
countri
around
half
death
occur
subsaharan
africa
estim
half
children
pneumonia
receiv
appropri
medic
care
addit
young
age
number
establish
risk
factor
incid
mortal
tabl
rudan
et
al
high
preval
low
birth
weight
g
babi
proteinenergi
malnutrit
earli
childhood
mani
resourcepoor
set
greatli
increas
pneumonia
risk
breastf
increas
risk
pneumonia
well
diarrhea
malnutrit
vitamin
defici
increas
risk
pneumoniarel
mortal
due
measl
evid
suggest
zinc
defici
associ
sever
diseas
lowincom
countri
communitybas
intervent
promot
regular
handwash
young
children
reduc
spread
respiratori
virus
decreas
incid
pneumonia
well
diarrhea
lubi
et
al
jefferson
et
al
set
exposur
indoor
air
pollut
due
burn
unprocess
solid
fuel
cook
heat
common
smith
et
al
nearli
half
household
worldwid
thought
cook
daili
unprocess
solid
fuel
biomass
coal
releas
time
pollut
cook
ga
stove
hiv
epidem
major
impact
child
pneumonia
particularli
highburden
set
eastern
central
southern
africa
prior
routin
use
cotrimoxazol
prevent
therapi
earli
antiretrovir
therapi
incid
sever
pneumonia
least
higher
hivinfect
compar
hivuninfect
infant
children
madhi
et
al
pneumoniarel
mortal
risk
also
much
higher
particularli
hivinfect
infant
pneumocysti
jirovecii
pneumonia
pcp
lead
caus
fatal
pneumonia
enarson
et
al
childhood
pneumonia
caus
wide
rang
pathogen
knowledg
common
caus
pathogen
highburden
set
import
inform
choic
antibiot
therapi
potenti
prevent
strategi
immun
howev
difficult
accur
determin
etiolog
limit
concern
clinic
sampl
laboratori
analysi
difficult
obtain
clinic
sampl
microbiolog
examin
lower
respiratori
tract
percutan
transthorac
fine
needl
lung
aspir
regard
gold
standard
sampl
rel
lowrisk
littl
practic
scott
hall
bronchoalveolar
lavag
gener
done
lowincom
countri
set
sputum
sampl
obtain
nebul
salin
induct
contamin
passag
upper
respiratori
tract
limit
diagnost
valu
blood
cultur
chest
radiograph
tradit
mainstay
diagnosi
blood
cultur
insensit
chest
radiographi
poorli
specif
addit
increasingli
recogn
etiolog
complex
involv
multipl
pathogen
etiolog
spectrum
childhood
pneumonia
vari
set
chang
time
respiratori
virus
promin
bacteri
pathogen
popul
better
socioeconom
condit
widespread
use
bacteri
conjug
vaccin
pneumoniarel
mortal
low
set
etiolog
studi
undertaken
lowincom
set
identifi
streptococcu
pneumonia
haemophilu
influenza
type
b
hib
common
bacteri
pathogen
caus
pneumonia
children
shann
studi
also
identifi
rang
viral
pathogen
respiratori
syncyti
rsv
influenza
virus
show
major
pneumoniarel
death
due
bacteri
rather
viral
pneumonia
except
measl
past
pneumonia
common
caus
death
children
measl
either
directli
due
measl
viru
giant
cell
pneumonia
commonli
due
secondari
bacteri
pneumonia
due
pneumonia
staphylococcu
aureu
children
immunosuppress
sever
malnourish
hivinfect
suscept
higher
incid
mortal
pneumonia
also
wider
spectrum
pathogen
addit
high
risk
pneumonia
due
common
bacteri
pathogen
also
develop
pneumonia
due
uncommon
gram
neg
bacteria
klebsiella
pneumonia
acinetobact
opportunist
pathogen
pneumocysti
jirovecii
mycobacterium
tuberculosi
also
like
children
suscept
pneumonia
nosocomi
infect
set
overcrowd
nutrit
rehabilit
unit
well
quantifi
describ
hivinfect
infant
pneumonia
often
one
potenti
pathogen
identifi
bacteria
virus
tuberculosi
pcp
cmv
infect
tuberculosi
gener
thought
associ
chronic
respiratori
symptom
infant
present
acut
sever
pneumonia
bacteri
coinfect
like
common
respons
initi
improv
frequent
observ
standard
antimicrobi
therapi
childhood
tuberculosi
virus
common
caus
child
pneumonia
high
middl
incom
set
predomin
caus
addit
virus
rsv
influenza
parainfluenza
adenovirus
rhinovirus
human
metapneumoviru
bocaviru
recent
identifi
viral
pneumonia
major
caus
morbid
caus
huge
burden
health
servic
mortal
gener
low
unless
underli
comorbid
coinfect
pathogen
caus
pneumonia
children
usual
selflimit
atyp
bacteria
mycoplasma
pneumonia
chlamydophila
speci
current
effort
provid
updat
etiolog
spectrum
pneumonia
era
widespread
use
conjug
hib
pneumococc
vaccin
includ
multicountri
pneumonia
etiolog
research
child
health
perch
studi
conduct
rang
set
africa
asia
levin
et
al
recent
studi
employ
wider
rang
sensit
diagnost
earlier
studi
howi
et
al
fever
cough
common
children
respiratori
tract
infect
pneumonia
clinic
find
indic
lower
respiratori
tract
infect
pneumonia
inspect
includ
increas
respiratori
rate
chest
indraw
recess
lower
costal
indraw
focu
clinic
definit
auscult
focal
abnorm
crackl
reduc
air
entri
may
present
commonli
found
infant
viral
pneumonia
instanc
due
rsv
commonli
gener
wheez
definit
tachypnea
fast
breath
agedepend
month
breath
per
minut
month
breath
per
minut
month
breath
per
minut
chest
indraw
gener
lower
costal
although
retract
may
note
sternal
suprastern
intercost
children
sever
pneumonia
may
addit
featur
poor
feed
head
nod
grunt
alter
mental
state
direct
evid
hypoxemia
way
puls
oximetri
presenc
cyanosi
establish
simpl
casemanag
approach
classifi
sever
pneumonia
guid
appropri
manag
reli
featur
readili
identifi
train
health
worker
fast
breath
lower
chest
indraw
tabl
overal
aim
casemanag
strategi
twofold
first
improv
outcom
child
pneumonia
provid
prompt
appropri
care
antibiot
oxygen
therapi
need
second
avoid
unnecessari
use
antibiot
children
respiratori
symptom
pneumonia
avoid
unnecessari
hospit
children
receiv
antibiot
home
chest
radiographi
requir
routin
clinic
assess
children
pneumonia
diagnost
tool
distinguish
bacteri
viral
pneumonia
chest
radiographi
indic
uncertainti
diagnosi
eg
suspect
pneumothorax
empyema
cardiac
failur
unsatisfactori
respons
firstlin
antibiot
children
sever
pneumonia
import
assess
whether
hypoxem
hypoxemia
common
children
sever
pneumonia
associ
mortal
subhi
et
al
accur
diagnost
tool
puls
oximetri
alway
avail
clinic
featur
indic
hypoxemia
cyanosi
alter
mental
state
poor
sensit
treatment
cap
children
empir
select
antimicrobi
determin
evidencebas
knowledg
common
bacteri
caus
sever
pneumonia
presenc
underli
risk
factor
sever
malnutrit
children
cap
treat
oral
therapi
addoyobo
et
al
recommend
home
care
case
sever
includ
chest
indraw
though
random
trial
evid
safe
home
treatment
pneumonia
chest
indraw
larg
south
asia
ashraf
et
al
hazir
et
al
evid
elsewher
notabl
africa
would
benefici
recommend
follow
antibiot
therapi
pneumonia
children
pneumonia
sever
oral
amoxicillin
l
set
high
hiv
infect
rate
give
oral
amoxicillin
least
mg
kg
per
dose
twice
day
day
l
area
low
hiv
preval
give
amoxicillin
least
mg
kg
per
dose
twice
day
day
give
first
dose
clinic
teach
mother
give
dose
home
sever
pneumonia
intraven
ampicillin
benzylpenicillin
gentamicin
l
ampicillin
mg
kg
benzylpenicillin
u
kg
im
iv
everi
h
least
day
l
gentamicin
mg
kg
im
iv
day
least
day
child
show
sign
improv
within
h
staphylococc
pneumonia
suspect
switch
gentamicin
mg
kg
im
iv
day
cloxacillin
mg
kg
im
iv
everi
h
p
use
ceftriaxon
mg
kg
im
iv
daili
case
failur
firstlin
treatment
high
middl
incom
countri
set
empir
antibiot
regimen
tend
differ
guidelin
macrolid
roxithromycin
azithromycin
often
use
outpati
manag
pneumonia
particularli
schoolag
children
due
preval
pathogen
mycoplasma
pneumonia
group
inpati
treatment
complic
pneumonia
broadspectrum
coverag
commonli
achiev
cephalosporin
betalactamas
inhibit
antimicrobi
combin
amoxicillin
clavulan
acid
suspect
staphylococc
pneumonia
agent
clindamycin
vancomycin
may
ad
convent
first
line
antistaphylococc
agent
cloxacillin
flucloxacillin
preval
methicillinresist
aureu
mrsa
appreci
presenc
confirm
metaanalysi
nine
studi
investig
impact
introduc
communitybas
case
manag
pneumonia
show
reduct
pneumoniarel
mortal
among
neonat
infant
children
year
respect
sazaw
et
al
communitybas
pneumonia
casemanag
strategi
part
integr
approach
care
sick
children
commun
primari
health
care
level
resourcelimit
set
improv
also
made
secondari
care
facil
district
hospit
introduct
structur
approach
pneumonia
tabl
casemanag
approach
diagnosi
manag
pneumonia
accord
world
health
organ
cough
difficulti
breath
l
oxygen
satur
central
cyanosi
l
sever
respiratori
distress
eg
grunt
sever
chest
indraw
l
sign
pneumonia
gener
danger
sign
inabl
breastfe
drink
lethargi
reduc
level
conscious
convuls
sever
casemanag
hypoxaemia
ensur
avail
antibiot
oxygen
enarson
et
al
duke
et
al
integr
commun
case
manag
iccm
pneumonia
malaria
diarrhea
increasingli
adopt
strategi
improv
access
poorest
underserv
children
treatment
diseas
unicef
releas
joint
statement
justifi
need
iccm
make
recommend
implement
integr
pneumonia
malaria
manag
rural
zambia
result
children
pneumonia
receiv
treatment
within
h
symptom
onset
oppos
children
refer
health
center
evalu
yeboahantwi
et
al
rural
uganda
clusterrandom
trial
compar
malaria
manag
versu
malaria
pneumonia
iccm
demonstr
children
integr
case
manag
area
like
receiv
prompt
appropri
antibiot
pneumonia
compar
children
area
malaria
manag
offer
kalyango
et
al
studi
demonstr
impact
earli
treatment
demonstr
iccm
safe
limit
high
qualiti
data
impact
strategi
allcaus
child
mortal
vaccin
increasingli
role
play
prevent
pneumonia
hib
import
caus
pneumonia
mening
highburden
lowincom
countri
gambia
hib
conjug
vaccin
demonstr
efficaci
hib
pneumonia
prevent
invas
hib
diseas
reduct
radiolog
confirm
pneumonia
mulholland
et
al
hib
conjug
vaccin
becom
part
routin
immun
program
infant
mani
countri
sinc
mark
reduct
invas
hib
diseas
note
pneumococc
conjug
vaccin
even
greater
potenti
reduc
burden
bacteri
pneumonia
mening
children
vaccin
trial
south
africa
gambia
demonstr
efficaci
vaccin
reduc
pneumonia
hospit
radiolog
confirm
pneumonia
case
gambia
reduct
allcaus
mortal
cutt
et
al
increas
evid
vaccin
young
children
pneumococc
conjug
vaccin
also
provid
protect
adult
popul
reduc
transmiss
pneumonia
seriou
complic
measl
recent
common
caus
death
associ
diseas
safe
effect
measl
vaccin
avail
decad
measlesrel
pneumonia
scourg
result
immun
optim
time
vaccin
strategi
vari
popul
addit
infant
lowincom
set
routin
receiv
vitamin
month
age
protect
measlesrel
mortal
child
develop
measl
receiv
addit
dose
vitamin
reduc
risk
complic
includ
pneumonia
addit
vaccin
effort
improv
earli
childhood
nutrit
notabl
exclus
breastfeed
first
month
help
protect
pneumonia
pneumoniarel
mortal
victora
et
al
reduct
exposur
indoor
air
pollut
primarili
cook
smoke
lowresourc
set
smith
et
al
household
overcrowd
may
also
reduc
risk
pneumonia
improv
access
healthcar
servic
reduc
morbid
mortal
great
potenti
reduc
impact
hiv
child
pneumonia
number
new
hiv
infect
babi
global
fall
year
due
antenat
hiv
screen
prevent
mothertochild
transmiss
cotrimoxazol
prevent
therapi
hivexpos
infect
infant
protect
pcp
common
caus
sever
pneumonia
death
hivinfect
infant
month
life
earli
antiretrovir
therapi
hivinfect
infant
reduc
pneumonia
risk
even
bacteri
conjug
vaccin
protect
hivinfect
infant
hivuninfect
infant
still
provid
protect
efficaci
import
given
high
burden
bacteri
pneumonia
hivinfect
infant
furthermor
may
vaccin
efficaci
may
improv
infant
receiv
antiretrovir
therapi
time
immun
data
confirm
final
infant
expos
tuberculosi
household
set
screen
tuberculosi
well
receiv
prevent
therapi
reduc
risk
develop
tuberculosi
overal
project
known
intervent
increasingli
substanti
impact
pneumonia
mortal
scale
success
increas
invest
lead
live
save
rapidli
bhutta
et
al
communityacquir
pneumonia
cap
adult
incid
pneumonia
differ
among
countri
rang
per
adult
per
year
unit
state
cap
affect
million
adult
account
million
hospit
admiss
year
pneumonia
influenza
sixth
lead
caus
death
ageadjust
mortal
attribut
diseas
rise
sever
popul
risk
cap
especi
due
streptococcu
pneumonia
peopl
year
older
immunocompromis
condit
anatom
function
asplenia
congest
heart
failur
copd
diabet
mellitu
liver
diseas
alcohol
smoke
strongest
risk
factor
invas
pneumococc
diseas
immunocompet
nonelderli
adult
hiv
infect
major
risk
factor
cap
adult
due
wide
rang
pathogen
includ
pneumococcu
tuberculosi
endem
set
tuberculosi
import
either
direct
caus
adult
pulmonari
tuberculosi
greater
risk
secondari
bacteri
pneumonia
longterm
care
facil
resid
repres
uniqu
highrisk
group
often
infect
mirror
hospitalacquir
pneumonia
may
also
suffer
communityacquir
pathogen
pneumonia
adult
adolesc
cap
usual
present
constel
symptom
sign
includ
cough
dyspnea
sputum
product
pleurit
chest
pain
although
nonrespiratori
symptom
mainli
elderli
patient
may
report
fewer
symptom
chang
mental
state
may
also
predomin
diagnosi
reli
clinic
find
patient
histori
physic
examin
radiolog
abnorm
metlay
et
al
wunderlink
water
presenc
infiltr
chest
xray
support
diagnosi
clinic
radiolog
featur
accur
predict
specif
etiolog
agent
case
cap
adult
due
key
pathogen
plethora
caus
agent
predomin
pathogen
observ
pneumonia
pneumococcu
histor
account
two
third
case
bacterem
pneumonia
widen
use
conjug
pneumococc
vaccin
adult
togeth
indirect
benefit
use
children
reduc
adult
exposur
chang
epidemiolog
adult
pneumococc
pneumonia
agent
vari
accord
sever
diseas
tabl
epidemiolog
condit
risk
factor
tabl
mandel
et
al
concurr
infect
multipl
microorgan
may
lead
cap
exampl
influenza
may
follow
secondari
infect
pneumonia
aureu
chlamydophila
pneumonia
may
also
follow
pneumonia
file
pneumonia
common
complic
caus
mortal
adolesc
young
adult
epidem
new
influenza
strain
recent
avian
influenza
swine
flu
epidem
import
issu
manag
patient
cap
concern
appropri
care
set
outpati
hospit
medic
ward
admiss
highdepend
unit
hdu
intens
care
unit
icu
adult
cap
low
risk
death
may
potenti
manag
home
decis
regard
hospit
usual
base
stabil
clinic
condit
risk
death
complic
presenc
absenc
medic
problem
social
characterist
sever
prognost
score
develop
evalu
use
identifi
patient
may
candid
outpati
treatment
wide
use
predict
score
pneumonia
sever
index
psi
stratifi
patient
five
risk
categori
higher
score
higher
risk
death
psi
categor
safe
manag
outpati
requir
short
period
observ
emerg
depart
hospit
consid
presenc
sever
cap
marker
easytous
version
psi
avail
internet
see
relev
websit
altern
score
use
bedsid
curb
lim
et
al
consider
presenc
hypotens
systol
blood
pressur
lower
hypoxemia
exacerb
activ
comorbid
inabl
reliabl
take
oral
tabl
common
caus
factor
communityacquir
pneumonia
patient
care
set
mandel
et
al
risk
factor
relat
specif
pathogen
communityacquir
pneumonia
mandel
et
al
medic
social
characterist
compromis
treatment
complianc
taken
account
evalu
need
hospit
admiss
metlay
fine
choic
diagnost
test
appropri
use
pneumonia
case
base
probabl
find
would
significantli
alter
standard
empir
manag
decis
sever
care
set
patient
suspicion
specif
pathogen
epidemiolog
basi
extens
test
outpati
suspect
bacteri
cap
option
low
probabl
treatment
failur
good
prognosi
recommend
empir
antibiot
treatment
presenc
epidemiolog
variabl
point
specif
pathogen
requir
differ
treatment
clearli
justifi
extens
test
blood
cultur
low
sensit
done
hospit
patient
especi
case
sever
cap
icu
patient
asplenia
liver
diseas
alcohol
abus
form
immunusuppress
presenc
cavitari
infiltr
suspicion
mrsa
figur
valid
expector
sputum
sampl
microbiolog
process
requir
polymorphonuclear
cell
less
epitheli
squamou
cell
per
highpow
microscop
field
obtain
whenev
possibl
especi
group
patient
mention
earlier
howev
collect
pretreat
expector
sputum
delay
initi
antibiot
administr
respiratori
sampl
endotrach
aspir
bronchoscop
obtain
recommend
patient
intub
sever
cap
set
obtain
lower
respiratori
sampl
feasibl
urinari
antigen
test
pneumonia
legionella
pneumophila
rapid
tool
abl
detect
pathogen
adult
reason
accuraci
even
antibiot
therapi
start
file
pneumonia
studi
adult
shown
sensit
specif
legionella
assay
avail
detect
l
pneumophila
serogroup
account
communityacquir
case
legionnair
diseas
sensit
rang
specif
nearli
recommend
antimicrobi
therapi
adult
base
integr
manag
adolesc
adult
ill
imai
lower
level
health
system
adolesc
adult
sever
pneumonia
defin
fast
breath
temperatur
c
puls
lethargi
unabl
walk
unassist
uncomfort
lie
sever
chest
pain
initi
dose
intramuscular
ceftriaxon
ampicillin
plu
gentamicin
administ
option
avail
chloramphenicol
recommend
second
line
agent
hivposit
patient
adult
danger
sign
eg
fast
breath
inabl
walk
unassist
treat
empir
pcp
cotrimoxazol
supplement
oxygen
appropri
patient
uncompl
pneumonia
defin
two
follow
fast
breath
night
sweat
chest
pain
oral
antibiot
administ
except
pregnant
women
trimest
hivposit
individu
stage
iv
diseas
low
count
admit
recommend
option
includ
amoxicillin
cotrimoxazol
second
line
agent
includ
erythromycin
azithromycin
doxycyclin
treatment
recommend
adult
develop
countri
set
also
depend
level
sever
cap
previous
healthi
outpati
macrolid
azithromycin
clarithromycin
erythromycin
recommend
howev
preval
drugresist
pneumonia
worldwid
increas
risk
factor
blactam
resist
defin
age
blactam
treatment
within
previou
month
alcohol
medic
comorbid
immunosuppress
diseas
treatment
despit
find
clinic
relev
remain
controversi
outcom
patient
betalactam
resist
pneumonia
usual
result
treatment
failur
addit
rate
pneumonia
macrolid
resist
risen
substanti
sever
part
world
contribut
increas
risk
macrolid
treatment
failur
daneman
et
al
therefor
prudent
treat
patient
respiratori
fluoroquinolon
levofloxacin
gatifloxacin
blactam
amoxicillin
g
tid
amoxicillinclavulan
bid
ceftriaxon
plu
macrolid
region
recogn
highresist
rate
nonicu
inpati
follow
treatment
option
recommend
respiratori
fluoroquinolon
blactam
plu
macrolid
icu
inpati
follow
regimen
minim
treatment
recommend
blactam
ceftriaxon
cefotaxim
ampicillinsulbactam
plu
fluoroquinolon
mandel
et
al
vaccin
pneumococci
influenza
remain
mainstay
prevent
cap
person
year
older
contact
highrisk
person
healthcar
worker
receiv
influenza
vaccin
pneumococc
polysaccharid
vaccin
recommend
peopl
year
older
immunocompromis
patient
anatom
function
asplenia
chronic
diseas
highrisk
pneumococc
diseas
congest
heart
failur
copd
diabet
mellitu
liver
diseas
alcohol
smoke
cessat
goal
person
particularli
pneumonia
increas
risk
invas
pneumococc
diseas
immunocompet
nonelderli
adult
smoke
risk
pneumococc
diseas
adult
fallen
countri
introduc
pneumococc
conjug
vaccin
infant
presum
reduc
transmiss
pneumococcu
young
children
adult
antiretrovir
therapi
cotrimoxazol
prevent
therapi
reduc
risk
cap
peopl
live
hiv
due
increas
recognit
atyp
pertussi
risk
adult
transmit
pertussi
sever
countri
advoc
use
acellular
pertussi
vaccin
hospitalacquir
pneumonia
hap
defin
pneumonia
occur
h
admiss
incub
time
admiss
pneumonia
common
nosocomi
infect
remain
inhospit
acquir
infect
highest
associ
mortal
overal
incid
hap
vari
per
admiss
highincom
set
substanti
higher
resourcelimit
set
highest
incid
report
icu
occur
patient
ventilatorassoci
pneumonia
vap
vaprel
mortal
high
host
characterist
advanc
age
femal
gender
underli
diseas
highersever
diseas
score
etiolog
nonfer
gramneg
bacilli
associ
poor
prognosi
inappropri
delay
antibiot
treatment
associ
higher
mortal
presenc
hap
increas
hospit
stay
averag
day
per
patient
account
larg
proport
antibiot
prescrib
addit
definit
establish
earlier
divers
popul
patient
found
spectrum
pathogen
caus
pneumonia
close
resembl
hap
multidrugresist
pathogen
tabl
pneumonia
group
patient
known
healthcareassoci
pneumonia
diagnost
therapeut
consider
similar
previous
mention
group
hap
vap
bonten
et
al
time
onset
pneumonia
import
epidemiolog
variabl
risk
factor
specif
pathogen
outcom
patient
hap
vap
earlyonset
pneumonia
defin
occur
within
first
day
hospit
usual
best
prognosi
like
caus
microorgan
alreadi
carri
host
commun
flora
pneumonia
h
influenza
aureu
anaerob
lateonset
pneumonia
day
like
caus
multidrugresist
pathogen
associ
poor
prognosi
pseudomona
aeruginosa
aureu
includ
methicillinresist
gram
neg
enter
bacilli
l
pneumophila
pneumonia
h
influenza
aspergillu
candida
speci
polymicrobi
clinic
featur
suggest
nosocomi
pneumonia
includ
presenc
new
persist
pulmonari
infiltr
temperatur
greater
c
less
c
white
blood
cell
count
greater
mm
less
mm
purul
secret
unfortun
mani
hospit
patient
present
find
reason
especi
intub
patient
thu
make
diagnosi
difficult
given
poor
accuraci
isol
clinic
find
score
clinic
find
modifi
clinic
pulmonari
infect
score
cpi
use
initi
decisionmak
score
base
previous
mention
find
oxygen
index
tabl
sum
greater
respiratori
sampl
justifi
empir
antibiot
treatment
begun
blood
cultur
recommend
circumst
permit
consid
diagnosi
nosocomi
pneumonia
unfortun
similar
situat
cap
sensit
low
specif
reduc
critic
ill
patient
risk
multipl
infecti
foci
import
challeng
manag
suspect
hap
avoid
inappropri
delay
antibiot
treatment
higher
mortal
entail
hand
prevent
emerg
multidrugresist
microorgan
avoid
indiscrimin
antibiot
prescript
achiev
dual
purpos
feasibl
lower
respiratori
tract
sampl
obtain
gram
stain
cultur
along
vitro
antibiot
suscept
test
guid
manag
bonten
et
al
ratio
arteri
po
mmhg
inspir
oxygen
fraction
patient
breath
spontan
respiratori
secret
obtain
expector
consider
cap
valid
sputum
diagnost
accuraci
sputum
hap
yet
establish
intub
patient
lower
respiratori
tract
cultur
obtain
via
bronchoscop
via
suction
cultur
semiquantit
quantit
differ
cutoff
point
discrimin
colon
infect
accord
method
quantit
cultur
invas
method
increas
specif
diagnosi
without
deleteri
consequ
order
facilit
diagnost
approach
tracheobronchi
aspir
gram
stain
semiquantit
quantit
cultur
cutoff
point
differenti
colon
infect
coloni
form
unitsml
quantit
method
canadian
critic
care
trial
group
obtain
figur
present
summari
manag
patient
inappropri
therapi
microorgan
sensit
antibiot
risk
factor
excess
mortal
multidrugresist
microorgan
frequent
pathogen
commonli
associ
inappropri
therapi
hand
delay
start
antibiot
therapi
may
increas
mortal
import
treat
probabl
etiolog
pathogen
promptli
empir
therapi
like
appropri
antibiot
select
base
protocol
design
base
local
evid
therapeut
guidelin
avail
bonten
et
al
may
adapt
accord
local
pattern
antibiot
resist
pneumonia
import
caus
morbid
mortal
children
adult
global
risk
factor
affect
incid
outcom
includ
extrem
age
poor
nutrit
immunosuppress
environment
exposur
socioeconom
determin
pneumonia
major
caus
communityacquir
bacteri
pneumonia
gram
neg
bacteria
often
resist
multipl
antibiot
common
caus
hospitalacquir
pneumonia
pneumonia
immunosuppress
individu
diagnosi
gener
clinic
manag
base
mainli
knowledg
like
caus
pathogen
well
clinic
sever
presenc
known
risk
factor
time
effect
antibiot
treatment
oxygen
therapi
hypoxem
critic
patient
outcom
prevent
measur
rang
improv
nutrit
hygien
specif
vaccin
target
common
caus
children
adult
pneumococc
influenza
vaccin
togeth
prevent
cur
measur
increasingli
substanti
impact
mortal
morbid
success
scale
global
see
also
bacteri
infect
overview
influenza
influenza
histor
measl
respiratori
diseas
overview
respiratori
infect
acut
respiratori
syncyti
viru
rhinovirus
streptococc
diseas
